Centerpoint Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19K Sell
89
-1
-1% -$214 0.01% 276
2026
Q1
$20K Hold
90
0.01% 243
2025
Q4
$23K Hold
90
0.01% 222
2025
Q3
$22K Sell
90
-1
-1% -$239 0.01% 238
2025
Q2
$22K Hold
91
0.01% 227
2025
Q1
$21K Hold
91
0.01% 233
2024
Q4
$19K Hold
91
0.01% 277
2024
Q3
$22K Hold
91
0.01% 257
2024
Q2
$20K Hold
91
0.01% 269
2024
Q1
$20K Hold
91
0.01% 247
2023
Q4
$20K Hold
91
0.01% 239
2023
Q3
$20K Sell
91
-1
-1% -$226 0.01% 230
2023
Q2
$21K Hold
92
0.01% 243
2023
Q1
$18K Hold
92
0.01% 275
2022
Q4
$17K Buy
+92
New +$16.2K 0.01% 228

Other funds holding STE

Centerpoint Advisors's STE Position: Q2 2026 in Review

Centerpoint Advisors reduced its Steris (STE) stake by 1.1% in Q2 2026, selling an estimated $214 and leaving 89 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #276.

Centerpoint Advisors first reported a position in STE in Q4 2022 and has held it in 15 quarters since. The position peaked at $23K in Q4 2025. 835 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Centerpoint Advisors held 89 shares of Steris worth $19K as of Q2 2026.
  • Centerpoint Advisors sold 1 Steris share in Q2 2026, an estimated $214.
  • Steris made up 0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #276 holding.
  • Centerpoint Advisors first reported a position in Steris in Q4 2022 and has held it in 15 quarters since.
  • Centerpoint Advisors's Steris position peaked at $23K in Q4 2025.
  • 835 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.